Dilated Cardiomyopathy: Does Etiological Heterogeneity Portend Clinical Heterogeneity?

  • L. Mestroni
  • C. Rocco
  • S. Miocic
  • A. Di Lenarda
  • G. Sinagra
  • D. Gregori
  • M. Vatta
  • M. Matulic
  • T. Zerjal
  • A. Falaschi
  • F. Camerini
  • M. Giacca
Conference paper


The etiology of dilated cardiomyopathy (DC), a disease of the myocardium characterized by dilatation and impaired contraction of the left ventricle or both ventricles, has been actively investigated for several decades. Unfortunately, the cause of DC is still mostly unknown and the diagnosis mainly based on the exclusion of any specific heart muscle disease, that is any disease associated with known cardiac or systemic disorders. However, it is expected that with the increasing understanding of the etiology and the pathogene-sis of DC, the difference between a true primary cardiomyopathy and specific heart muscle diseases will become indistinguishable in the future [1].


Dilate Cardiomyopathy Idiopathic Dilate Cardiomyopathy Dystrophin Gene Becker Muscular Dystrophy Conduction System Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Report of the 1995 World Health Organization/International Society and Federation of Cardiolgy Task Force on the Definition and Classification of Cardiomyopathies (1996) Circulation 93:841–842CrossRefGoogle Scholar
  2. 2.
    Kasper ED, Agema WRP, Hutchins GM, Deckers JW, Hare JM, Baughman KL (1994) The causes of dilated cardiomyopathy:A clinicopathologic review of 673 consecutive patients. J Am Coll Cardiol 23:586–590PubMedCrossRefGoogle Scholar
  3. 3.
    Aretz H, Billingham M, Edwards W, Factor S, Fallon J, Fenoglio J, Olsen E, Schoen F (1986) Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol 1:3–14Google Scholar
  4. 4.
    Grasso M, Arbustini E, Silini E, Diegoli M, Percivalle E, Ratti G, Bramerio M, Gavazzi A, Vigano M, Milanesi G (1992) Search for coxsackievirus B3 RNA in idiopathic dilated cardiomyopathy using gene amplification by polymerase chain reaction. Am J Cardiol 69:658–664PubMedCrossRefGoogle Scholar
  5. 5.
    Jin O, Sole MJ, Butany JW, Chia W-K, McLaughlin PR, Liu P, Liew C-C (1990) Detection of enterovirus RNA in myocardial biopsies from patients with myocarditis and cardiomyopathy using gene amplification by polymerase chain reaction. Circulation 82:8–16PubMedCrossRefGoogle Scholar
  6. 6.
    Weiss LM, Liu X-F, Chang KL, Billingham ME (1992) Detection of eneteroviral RNA in idiopathic dilated cardiomyopathy and other human cardiac tissues. J Clin Invest 90:156–159PubMedCrossRefGoogle Scholar
  7. 7.
    Bowles N, Rose M, Taylor P, Banner N, Morgan-Capner P, Cunningham L, Archard L, Yacoub M (1989) End-stage dilated cardiomyopathy: persistence of enterovirus RNA in myocardium et cardiac transplantation and lack of immune response. Circulation 80:1128–1136PubMedCrossRefGoogle Scholar
  8. 8.
    Giacca M, Severini GM, Mestroni L, Salvi A, Lardieri G, Falaschi A, Camerini F (1994) Low frequency of detection by nested polymerase chain reaction of enterovirus ribonucleic acid in endomyocardial tissue of patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 24:1033–1040PubMedCrossRefGoogle Scholar
  9. 9.
    Why JF, Meany BT, Richardson PJ, Olsen E, Bowles NE, Cunningham L, Freeke CA, Archard LC (1994) Clinical and prognostic significance of detection of enteroviral RNA in the myocardium of patients with myocarditis or dilated cardiomyopathy. Circulation 89:2582–2588PubMedCrossRefGoogle Scholar
  10. 10.
    Figulla H, Stille-Siegener M, Mall G, Heim A, Kreuzer H (1995) Myocardial enterovirus infection with left ventricular dysfunction: a benign disease compared with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 25:1170–1175PubMedCrossRefGoogle Scholar
  11. 11.
    Martin A, Webber S, Fricker F, Jaffe R, Demmler G, Kearney D, Zhang Y, Bodurtha J, Gelb B, Ni J, Bricker T, Towbin J (1994) Acute myocarditis: rapid diagnosis by PCR in children. Circulation 90:330–339PubMedCrossRefGoogle Scholar
  12. 12.
    Fowles RE, Bieber CR, Stinson EB (1979) Defective in vitro suppressor cell function in idiopathic dilated cardiomyopathy. Circulation 59:483–491PubMedCrossRefGoogle Scholar
  13. 13.
    Eckstein R, Mempel W, Boite HD (1982) Reduced suppressor cell activity in congestive cardiomyopathy. Circulation 65:1224–1229PubMedCrossRefGoogle Scholar
  14. 14.
    Anderson JL, Carlquist JF, Higashikubo R (1985) Quantitation of lymphocyte subset by immunofluorescence flow cytometry in idiopathic dilated cardiomyopathy. Am J Cardiol 55:1550–1554PubMedCrossRefGoogle Scholar
  15. 15.
    Maisch B, Bauer E, Herzum M, Hufnagel G, Izumi T, Nunoda S, Schönian U (1990) Humoral and cell-mediated immunity: pathogenetic mechanisms in dilated cardiomyopathy. In: Baroldi G, Camerini F, Goodwin JF (eds) Advances in cardiomyopathies. Springer-Verlag, Berlin Heidelberg New York, pp 209–220CrossRefGoogle Scholar
  16. 16.
    Caforio ALP, Grazzini M, Mann JM, Keeling PJ, Bottazzo GF, McKenna WJ, Schiaffino S (1992) Identification of a and β-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 85:1734–1742PubMedCrossRefGoogle Scholar
  17. 17.
    Schulze K, Becker BF, Schauer R, Schultheiss HP (1990) Antibodies to ADP-ATP carrier — an autoantigen in myocarditis and dilated cardiomyopathy — impair cardiac function. Circulation 81:959–969PubMedCrossRefGoogle Scholar
  18. 18.
    Magnusson Y, Wallukat G, Waagstein F, Hjalmarson A, Hoebeke J (1994) Characterization of antibodies against the betal-adrenoreceptor with positive chronotropic effect. Circulation 89:2760–2767PubMedCrossRefGoogle Scholar
  19. 19.
    Fu L-X, Magnusson Y, Bergh C-H, Liljeqvist JÅ, Waagstein F, Hjalmarson Å, Hoebeke J (1993) Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest 91:1964–1968PubMedCrossRefGoogle Scholar
  20. 20.
    Carlquist JF, Menlove RL, Murray MB, O’Connell JB, Anderson JL (1991) HLA class II (DR and DQ) antigen associations in idiopathic dilated cardiomyopathy. Validation study and meta-anlysis of published HLA association studies. Circulation 83:515–522Google Scholar
  21. 21.
    Mestroni L, Martinetti M, Cappello N, Misefari V, Giacca M, Camerini F (1992) HLA linkage analysis in familial dilated cardiomyopathy and right ventricular dysplasia. Circulation 86:I–794Google Scholar
  22. 22.
    Olson TM, Thibodeau SN, Lundquist PA, Schaid DJ, Michels VV (1995) Exclusion of a primary gene defect at the HLA locus in familial idiopathic dilated cardiomyopathy. J Med Genet 32:876–880PubMedCrossRefGoogle Scholar
  23. 23.
    Caforio ALP, Bonifacio E, Stewart JT, Neglia D, Parodi O, Bottazzo F, McKenna W (1990) Novel organ-specific circulating cardiac autoantibodies in dilated cardiomyopathy. J Am Coll Cardiol 15:1527–1534PubMedCrossRefGoogle Scholar
  24. 24.
    Caforio ALP, Keeling PJ, Zachara E, Mestroni L, Camerini F, Mann JM, Bottazzo GF, McKenna WJ (1994) Evidence from family studies for autoimmunity in dilated cardiomyopathy. Lancet 344:773–777PubMedCrossRefGoogle Scholar
  25. 25.
    Michels VV, Moll PP, Miller FA, Tajik AJ, Chu JS, Driscoll DJ, Burnett JC, Rodeheffer RJ, Chesebro JH, Tazelaar H (1992) The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 326:77–82PubMedCrossRefGoogle Scholar
  26. 26.
    Keeling PJ, Gang G, Smith G, Seo H, Bent SE, Murday V, Caforio ALP, McKenna WJ (1995) Familial dilated cardiomyopathy in the United Kingdom. Br Heart J 73:417–421PubMedCrossRefGoogle Scholar
  27. 27.
    Gregori D, Rocco C, Di Lenarda A, Sinagra G, Miocic S, Camerini F, Mestroni L (1996) Estimating the frequency of familial dilated cardiomyopathy, and the risk of misclassification errors. Circulation 94:1–270CrossRefGoogle Scholar
  28. 28.
    Mestroni L, Milasin J, Vatta M, Pinamonti B, Sinagra G, Rocco C, Matulic M, Falaschi A, Giacca M, Camerini F (1996) Genetic factors in dilated cardiomyopathy. Arch Mal Coeur 89(II):15–20PubMedGoogle Scholar
  29. 29.
    Krajinovic M, Mestroni L, Severini GM, Pinamonti B, Camerini F, Falaschi A, Giacca M (1994) Absence of linkage between idiopathic dilated cardiomyopathy and candidate genes involved in the immune function in a large Italian pedigree. J Med Genet 31:766–771PubMedCrossRefGoogle Scholar
  30. 30.
    Mestroni L, Krajinovic M, Severini GM, Falaschi A, Giacca M, Camerini F (1994) Molecular genetics of dilated cardiomyopathy. Herz 19:97–104PubMedGoogle Scholar
  31. 31.
    Krajinovic M, Pinamonti B, Sinagra G, Vatta M, Severini GM, Milasin J, Falaschi A, Camerini F, Giacca M, Mestroni L (1995) Linkage of familial dilated cardiomyopathy to chromosome 9. Am J Hum Genet 57:846–852PubMedGoogle Scholar
  32. 32.
    Durand J-B, Bachinski LL, Bieling LC, Czernuszewicz GZ, Abchee AB, Yu QT, Tapscott T, Hill R, Ifegwu J, Marian AJ, Brugada R, Daiger S, Gregoritch JM, Anderson JL, Quinones M, Towbin J, Roberts R (1995) Localization of a gene responsible for familial dilated cardiomyopathy to chromosome 1q32. Circulation 92:3387–3389PubMedCrossRefGoogle Scholar
  33. 33.
    Bowles KL, Gajarski R, Porter P, Goytia V, Bachinski L, Roberts R, Pignatelli R (1996) Gene mapping of familial autosomal dominant dilated cardiomyopathy to chromosome 10q21-23. J Clin Invest 98:1355–1360PubMedCrossRefGoogle Scholar
  34. 34.
    Graber HL, Unverferth DV, Baker PB, Rayan JM, Baba N, Wooley CF (1986) Evolution of a hereditery cardiac conduction and muscle disorder: a study involving a family with six generations affected. Circulation 74:325–327CrossRefGoogle Scholar
  35. 35.
    Mestroni L, Miani D, Di Lenarda A, Silvestri F, Bussani R, Filippi G, Camerini F (1990) Clinical and pathologic study of familial dilated cardiomyopathy. Am J Cardiol 65:1449–1453PubMedCrossRefGoogle Scholar
  36. 36.
    Kass S, MacRae C, Graber HL, Sparks EA, McNamara D, Boudoulas H, Basson CT, Baker III PB, Cody RJ, Fishman MC, Cox N, Kong A, Wooley CF, Seidman JG, Seidman CE (1994) A gene defect that causes conduction system disease and dilated cardiomyopathy maps to chromosome 1p1-1q1. Nature Genet 7:546–551PubMedCrossRefGoogle Scholar
  37. 37.
    Olson TM, Keating MT (1996) Mapping a cardiomyopathy locus to chromosome 3p22-p25. J Clin Invest 97:528–532PubMedCrossRefGoogle Scholar
  38. 38.
    Ahn AH, Kunkel LM (1993) The structural and functional diversity of dystrophin. Nature Genet 3:283–291PubMedCrossRefGoogle Scholar
  39. 39.
    Towbin JA, Hejtmancik F, Brink P, Gelb BD, Zhu XM, Chamberlain JS, McCabe ERB, Swift M (1993) X-linked cardiomyopathy (XLCM): molecular genetic evidence of linkage to the Duchenne muscular dystrophy (dystrophin) gene at the Xp21 locus. Circulation 87:1854–1865PubMedCrossRefGoogle Scholar
  40. 40.
    Muntoni F, Cau M, Ganau A, Congiu R, Arvedi G, Mateddu A, Morrosu MG, Cianchetti C, Realdi G, Cao A, Melis MA (1993) Deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med 329:921–925PubMedCrossRefGoogle Scholar
  41. 41.
    Berko B, Swift M (1987) X-linked dilated cardiomyopathy. N Engl J Med 316:1186–1191PubMedCrossRefGoogle Scholar
  42. 42.
    Yoshida K, Ikeda SI, Nakamura A, Kagoshima M, Takeda S, Shoji S, Yanagisawa N (1993) Molecular analysis of the Duchenne muscular dystrophy gene in patients with Becker muscular dystrophy presenting with dilated cardiomyopathy. Muscle & Nerve 16:1161–1166CrossRefGoogle Scholar
  43. 43.
    Milasin J, Muntoni F, Severini GM, Bartoloni L, Vatta M, Krajinovic M, Mateddu A, Angelini C, Camerini F, Falaschi A, Mestroni L, Giacca M (1996) A point mutation in the 5’ splice site of the dystrophin gene first intron responsible for X-linked dilated cardiomyopathy. Hum Mol Genet 5:73–79PubMedCrossRefGoogle Scholar
  44. 44.
    Muntoni F, Wilson L, Marrosu MG, Cianchetti C, Mestroni L, Ganau A, Dubowitz V, Sewry C (1995) A mutation in the dystrophin gene selectively affecting dystrophin expression in the heart. J Clin Invest 96:693–699PubMedCrossRefGoogle Scholar
  45. 45.
    Ortiz-Lopez R, Li H, Su J, Goytia V, Towbin JA (1997) Evidence for a dystrophin missense mutation as a cause of X-linked dilated cardiomyopathy (XLCM). Circulation 95:2434–2440PubMedCrossRefGoogle Scholar
  46. 46.
    Melacini P, Fanin M, Danieli GA, Fasoli G, Villanova C, Angelini C, Vitiello L, Miorelli M, Buja GF, Mostacciuolo ML, Pegoraro E, Dalla Volta S (1993) Cardiac involvement in Becker muscular dystrophy. J Am Coll Cardiol 22:1927–1934PubMedCrossRefGoogle Scholar
  47. 47.
    Mestroni L, Muntoni F, Milasin J, Di Lenarda A, Sinagra G, Rocco C, Vatta M, Matulic M, Falaschi A, Camerini F, Giacca M (1996) Familial dilated cardiomyopathy with subclinical skeletal muscle involvement. Circulation 94:I–271Google Scholar
  48. 48.
    Fadic R, Sunada Y, Waclawik AJ, Buck S, Lewandoski PJ, Campbell KP, Lotz BP (1996) Brief report: deficiency of a dystrophin-associated glycoprotein (adhalin) in a patient with muscular dystrophy and cardiomyopathy. N Engl J Med 334:362–366PubMedCrossRefGoogle Scholar
  49. 49.
    Maeda M, Holder E, Lowes B, Valent S, Bies RD (1997) Dilated cardiomyopathy associated with deficiency of the cytoskeletal protein metavinculin. Circulation 95:17–20PubMedCrossRefGoogle Scholar
  50. 50.
    Nigro V, Okazaki Y, Belsito A, Piluso G, Matsuda Y, Politano L, Nigro G, Ventura C, Abbondanza C, Molinari AM, Acampora D, Nishimura M, Hayashizaki Y, Puca GA (1997) Identification of the Syrian Hamster cardiomyopathy gene. Hum Mol Genet 6:601–607PubMedCrossRefGoogle Scholar
  51. 51.
    Suomalainen A, Paetau A, Leinonen H, Majander A, Peltonen L, Somer H (1992) Inherited dilated cardiomyopathy with multiple deletions of mitochondrial DNA. Lancet 340:1319–1320PubMedCrossRefGoogle Scholar
  52. 52.
    Santorelli FM, Mak S-C, El-Schahawi M, Casali C, Shanske S, Baram TZ, Madrid RE, DiMauro S (1996) Maternally inherited cardiomyopathy associated with a novel mutation in the mitochondrial tRNA Lys gene (G8363A). Am J Hum Genet 58:933–939PubMedGoogle Scholar
  53. 53.
    Zeviani M, Gellera C, Antozzi C, Rimoldi M, Morandi L, Villani F, Tiranti V, DiDonato S (1991) Maternally inherited myopathy and cardiomyopathy: association with mutation in mitochondrial DNA tRNA Leu(UUR). Lancet 338:143–147PubMedCrossRefGoogle Scholar
  54. 54.
    Grasso M, Fasani R, Diegoli M, Bianchieri N, Porcu E, Concardi M, Pilotto A, Fortina P, Surrey S, Vigano’ M, Arbustini E (1995) Mitochondrial DNA base changes in sporadic and familial dilated cardiomyopathy (DCM) and in controls. J Mol Med 73:A28Google Scholar
  55. 55.
    Mestroni L, Giacca M (1997) Molecular genetics of dilated cardiomyopathy. Curr Op Cardiol 12:303–309CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1998

Authors and Affiliations

  • L. Mestroni
  • C. Rocco
  • S. Miocic
  • A. Di Lenarda
  • G. Sinagra
  • D. Gregori
  • M. Vatta
  • M. Matulic
  • T. Zerjal
  • A. Falaschi
  • F. Camerini
  • M. Giacca

There are no affiliations available

Personalised recommendations